ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,804Medicare Part D Prescriptions Filled, Including Refills

Rank: 174 out of 890

$638K Total Retail Price of All Prescriptions

Rank: 175 out of 890

660 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,096 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 492 470 1 2
PRAVASTATIN SODIUM 384 330 2 10
AMLODIPINE BESYLATE 352 280 3 1
HYDROCODONE-ACETAMINOPHEN 303 244 S3 4 3
LISINOPRIL 298 249 5 4
OMEPRAZOLE 269 231 6 8
HYDROCHLOROTHIAZIDE 248 227 7 9
SIMVASTATIN 224 205 8 5
ZOLPIDEM TARTRATE 221 185 9 19
GABAPENTIN 210 161 10 12
METOPROLOL SUCCINATE 180 131 11 17
ATORVASTATIN CALCIUM 178 170 12 13
ALENDRONATE SODIUM 168 164 13 38
ALLOPURINOL 167 155 14 31
TRAMADOL HCL 166 134 15 16
FUROSEMIDE 164 138 16 7
NEXIUM 162 152 17 14
LOSARTAN POTASSIUM 162 141 17 29
SERTRALINE HCL 160 146 19 26
FLUTICASONE PROPIONATE 158 136 20 39
MELOXICAM 143 120 21 18
TAMSULOSIN HCL 137 133 22 32
PANTOPRAZOLE SODIUM 135 134 23 34
ATENOLOL 134 133 24 23
BENAZEPRIL HCL 134 124 24 44
METOPROLOL TARTRATE 128 119 26 15
CRESTOR 127 110 27 25
METFORMIN HCL 119 83 28 6
WARFARIN SODIUM 119 115 28 24
METFORMIN HCL ER 117 87 30 54
CITALOPRAM HBR 113 85 31 20
DONEPEZIL HCL 109 109 32 30
SPIRIVA 109 93 32 66
POTASSIUM CHLORIDE 107 90 34 11
SYNTHROID 105 105 35 53
AMITRIPTYLINE HCL 104 81 R 36 43
CARVEDILOL 97 91 37 22
GLIMEPIRIDE 93 79 38 27
CYMBALTA 86 71 39 45
CELEBREX 78 65 40 91
TRAZODONE HCL 76 49 41 40
LOVASTATIN 73 65 42 46
MIRTAZAPINE 72 60 43 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 63 44 21
ESTRADIOL 65 51 R 45 118
CLOPIDOGREL 64 53 46 28
RANITIDINE HCL 63 47 47 49
ESCITALOPRAM OXALATE 63 59 47 51
VENLAFAXINE HCL ER 58 48 49 114
ADVAIR DISKUS 55 52 50 52
LOSARTAN-HYDROCHLOROTHIAZIDE 54 49 51 57
CIPROFLOXACIN HCL 53 50 52 58
AZITHROMYCIN 53 46 52 37
PREDNISONE 53 51 52 47
ISOSORBIDE MONONITRATE ER 52 47 55 60
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 56 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.